Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)

Summary

The study is designed to determine the effect of weekly intramuscular (IM) administration of 30 mcg Avonex (interferon beta 1a) on safety parameters and gadolinium (Gd) enhanced and T2-weighted cranial magnetic resonance imaging (MRI) lesions in Chinese patients with clinically diagnosed (using revised McDonald criteria) relapsing multiple sclerosis (MS).

Timeline

Start

2010-04

Primary completion

2011-10

Completion

2011-10

Drugs

Indications